Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
Aim. Increasing evidence supports the role of the gut microbiota in the etiology of ulcerative colitis (UC). Fecal microbiota transplantation (FMT) is a highly effective treatment against recurrent Clostridium difficile infection; however, its efficacy in UC is still controversial. A systematic revi...
Saved in:
Main Authors: | Xiaolei Liu, Yan Li, Kaichun Wu, Yongquan Shi, Min Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/6612970 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01) -
The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
by: Wai Ching Lam, et al.
Published: (2019-01-01) -
Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut–brain axis
by: Mahdis Morshedbak, et al.
Published: (2025-02-01) -
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019-01-01) -
Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
by: Vendel Kristensen, et al.
Published: (2017-01-01)